Remodeling the Multiple Myeloma Bone Marrow Microenvironment with CART Cells to Overcome Resistance
Jennifer Meyer Feigin, Saad S. Kenderian(Mayo Clinic in Arizona), Elizabeth L. Siegler(Mayo Clinic), Carli M. Stewart(WinnMed), Wannakorn Khopanlert, Olivia Sirpilla, Ekene J. Ogbodo(Mayo Clinic), Grace DeFranco, Mehrdad Hefazi(Mayo Clinic), Claudia Manriquez-Roman, Brooke Kimball(Mayo Clinic), Omar L. Gutierrez-Ruiz(Mayo Clinic in Arizona), Xia Hong(Hubei University of Medicine), Diane F. Jelinek(Mayo Clinic in Arizona), Dominic Skeele, Long K, Ismail Can, R. Leo Sakemura, Kun Yun, P. Leif Bergsagel, Yi Lin, Truc N. Huynh, Ateka Saleh, Sophia Y. Goldberg, Matthew J. Schellenberg(Mayo Clinic)
Cited by 0
Related Papers
Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2019|735
Focal Adhesion Kinase Is Upstream of Phosphatidylinositol 3-Kinase/Akt in Regulating Fibroblast Survival in Response to Contraction of Type I Collagen Matrices via a β1 Integrin Viability Signaling Pathway
|Journal of Biological Chemistry|2004|358
Deficiency of terminal ADP‐ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease
|The EMBO Journal|2013|309
Regulated Expression of BAFF-Binding Receptors during Human B Cell Differentiation
|The Journal of Immunology|2007|261